Seroatlas · Human Serome Atlas

LILRB4

Leukocyte immunoglobulin-like receptor subfamily B member 4

Also known as: CD85k, HM18, ILT3, LIR-5, LIR5, LIRB4_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8NHJ6
Gene
LILRB4
Ensembl
ENSG00000186818
Chromosome
19
Canonical length
448 aa
Protein class
CD markers, Predicted intracellular proteins, Predicted membrane proteins

OverviewNCBI Gene

This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13.4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. The receptor can also function in antigen capture and presentation. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

448 residues, UniProt reviewed canonical sequence.

>Q8NHJ6|LILRB4
     1  MIPTFTALLC LGLSLGPRTH MQAGPLPKPT LWAEPGSVIS WGNSVTIWCQ GTLEAREYRL
    61  DKEESPAPWD RQNPLEPKNK ARFSIPSMTE DYAGRYRCYY RSPVGWSQPS DPLELVMTGA
   121  YSKPTLSALP SPLVTSGKSV TLLCQSRSPM DTFLLIKERA AHPLLHLRSE HGAQQHQAEF
   181  PMSPVTSVHG GTYRCFSSHG FSHYLLSHPS DPLELIVSGS LEDPRPSPTR SVSTAAGPED
   241  QPLMPTGSVP HSGLRRHWEV LIGVLVVSIL LLSLLLFLLL QHWRQGKHRT LAQRQADFQR
   301  PPGAAEPEPK DGGLQRRSSP AADVQGENFC AAVKNTQPED GVEMDTRQSP HDEDPQAVTY
   361  AKVKHSRPRR EMASPPSPLS GEFLDTKDRQ AEEDRQMDTE AAASEAPQDV TYAQLHSFTL
   421  RQKATEPPPS QEGASPAEPS VYATLAIH

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against LILRB4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.52
Highest tissue expression
18 nTPM

Expression across tissuesHPA

Tissue

  • spleen: 18 nTPM
  • spinal cord: 14 nTPM
  • lung: 13 nTPM
  • lymph node: 11 nTPM
  • appendix: 11 nTPM
  • blood vessel: 11 nTPM

Single-cell type

  • microglia: 139 nCPM
  • kupffer cells: 10 nCPM
  • monocytes: 9.1 nCPM
  • macrophages: 8.6 nCPM
  • pdcs: 7.6 nCPM
  • monocyte progenitors: 5.5 nCPM

Immune cell

  • plasmacytoid DC: 38 nTPM
  • myeloid DC: 12 nTPM
  • intermediate monocyte: 11 nTPM
  • non-classical monocyte: 9 nTPM
  • classical monocyte: 7.9 nTPM
  • total PBMC: 3.8 nTPM

Brain region

  • medulla oblongata: 3.6 nTPM
  • pons: 3 nTPM
  • white matter: 3 nTPM
  • midbrain: 2.8 nTPM
  • spinal cord: 2.8 nTPM
  • thalamus: 2.4 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.34
gnomAD pLI
0
gnomAD missense Z
-1.43
DepMap mean gene effect
0.1
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of LILRB4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads LILRB4 as an antibody target. Whether an autoantibody or antibody against LILRB4 could matter depends on whether native LILRB4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

LILRB4 is annotated at the cell surface, where native LILRB4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label LILRB4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/LILRB4. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...